LifeMD annual free cash flow
2020
2021
2022
2023
2024
2025
LifeMD Free Cash Flow (FCF) History (LFMD)
LifeMD reported $6.4M in free cash flow for fiscal 2025, a decrease of 60.06% from the previous fiscal year, with a free cash flow margin of 3.30%.
View full LifeMD company overviewLifeMD free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $6.4M | −$9.6M | −60.06% | +3.30% |
| 2024 | 2024-12-31 | $16.0M | $7.4M | +86.27% | +10.37% |
| 2023 | 2023-12-31 | $8.6M | $31.9M | — | +5.65% |
| 2022 | 2022-12-31 | −$23.3M | $10.0M | — | −19.58% |
| 2021 | 2021-12-31 | −$33.3M | −$20.8M | — | −35.89% |
| 2020 | 2020-12-31 | −$12.5M | — | — | −33.60% |
LifeMD quarterly free cash flow
Q1.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$7.0M | −$14.9M | — | −14.79% |
| Q1 2026 | 2026-03-31 | $339,446 | −$2.6M | −88.50% | +0.68% |
| Q4 2025 | 2025-12-31 | −$3.4M | −$4.3M | — | −10.11% |
| Q3 2025 | 2025-09-30 | −$968,135 | −$7.2M | — | −1.61% |
| Q2 2025 | 2025-06-30 | $7.9M | $4.0M | +101.73% | +16.04% |
| Q1 2025 | 2025-03-31 | $3.0M | −$2.1M | −41.30% | +5.80% |
| Q4 2024 | 2024-12-31 | $875,391 | −$4.7M | −84.38% | +12.98% |
| Q3 2024 | 2024-09-30 | $6.3M | $5.2M | +497.56% | +11.73% |
| Q2 2024 | 2024-06-30 | $3.9M | −$716,051 | −15.52% | +7.69% |
| Q1 2024 | 2024-03-31 | $5.0M | $7.7M | — | +11.39% |
| Q4 2023 | 2023-12-31 | $5.6M | $7.6M | — | +12.49% |
| Q3 2023 | 2023-09-30 | $1.0M | $3.8M | — | +2.71% |
| Q2 2023 | 2023-06-30 | $4.6M | $14.8M | — | +12.83% |
| Q1 2023 | 2023-03-31 | −$2.6M | $5.7M | — | −7.99% |
| Q4 2022 | 2022-12-31 | −$2.0M | $4.6M | — | −7.05% |
| Q3 2022 | 2022-09-30 | −$2.8M | $4.7M | — | −8.91% |
| Q2 2022 | 2022-06-30 | −$10.2M | $1.4M | — | −33.45% |
| Q1 2022 | 2022-03-31 | −$8.4M | $797,395 | — | −28.78% |
| Q4 2021 | 2021-12-31 | −$6.6M | −$1.8M | — | −24.01% |
| Q3 2021 | 2021-09-30 | −$7.5M | −$8.1M | — | −29.95% |
| Q2 2021 | 2021-06-30 | −$11.6M | — | — | −52.15% |
| Q1 2021 | 2021-03-31 | −$9.2M | — | — | −50.31% |
| Q3 2020 | 2020-09-30 | −$4.8M | — | — | −43.25% |
| Q1 2020 | 2020-03-31 | $592,955 | — | — | +13.77% |
LifeMD free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$12.5M to $6.4M, a net increase of $18.9M. LifeMD's latest reported quarter, Q2 2026, generated −$7.0M in free cash flow, a decrease of $14.9M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review LifeMD filings at SEC.gov ↗